drugset
drugset / Trial / NCT02062255

Impact of COX2 on Sera Biomarkers From Obese Subjects

NCT02062255 ↗

Phase 0 Completed 126 enrolled The University of Texas Health Science Center at San Antonio
RandomizedSingle-groupOpen-labelBasic science

Summary

Obesity promotes worse outcome for post-menopausal breast cancer patients.

Timeline

Start
2013-10
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg Oral

Indications

female breast carcinoma